openPR Logo
Press release

Atopic Keratoconjuctivitis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Akari Therapeutics, Allakos

11-07-2023 06:40 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Atopic Keratoconjuctivitis Pipeline Analysis (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Atopic Keratoconjuctivitis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Atopic Keratoconjuctivitis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Atopic Keratoconjuctivitis Therapeutics Market.

The report provides a detailed description of the Atopic Keratoconjuctivitis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Atopic Keratoconjuctivitis Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/atopic-keratoconjuctivitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Atopic Keratoconjuctivitis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Atopic Keratoconjuctivitis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Atopic Keratoconjuctivitis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Atopic Keratoconjuctivitis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Atopic Keratoconjuctivitis treatment market.

Learn More about the Clinical and Commercial Development Activities in the Atopic Keratoconjuctivitis Therapeutics Domain @
https://www.delveinsight.com/report-store/atopic-keratoconjuctivitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Atopic Keratoconjunctivitis Therapeutics Analysis
There are approx. 10+ key companies developing therapies for Atopic Keratoconjuctivitis. Currently, Akari Therapeutics is leading the therapeutics market with its Atopic Keratoconjuctivitis drug candidates in the most advanced stage of clinical development.

Atopic Keratoconjuctivitis Companies in the Therapeutics Market Include:
• Akari Therapeutics
• Allakos
And Many Others

Emerging and Marketed Atopic Keratoconjuctivitis Therapies Covered in the Report Include:
• rVA576: Akari Therapeutics
rVA576 is being developed by Akari Therapeutics for the treatment of Atopic Keratoconjunctivitis. The trial was initiated in February 2019.

Get an in-depth Assessment of the Emerging Therapies and Atopic Keratoconjuctivitis Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/atopic-keratoconjuctivitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Atopic Keratoconjuctivitis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Atopic Keratoconjuctivitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Atopic Keratoconjuctivitis Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/atopic-keratoconjuctivitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Atopic Keratoconjuctivitis Current Treatment Patterns
4. Atopic Keratoconjuctivitis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Atopic Keratoconjuctivitis Late-Stage Products (Phase-III)
7. Atopic Keratoconjuctivitis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Atopic Keratoconjuctivitis Discontinued Products
13. Atopic Keratoconjuctivitis Product Profiles
14. Atopic Keratoconjuctivitis Companies
15. Atopic Keratoconjuctivitis Drugs
16. Dormant and Discontinued Products
17. Atopic Keratoconjuctivitis Unmet Needs
18. Atopic Keratoconjuctivitis Future Perspectives
19. Atopic Keratoconjuctivitis Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/atopic-keratoconjuctivitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Erectile Dysfunction Market
https://www.delveinsight.com/report-store/erectile-dysfunction-market

Varicose Ulcer Market
https://www.delveinsight.com/report-store/varicose-ulcer-market

Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor Pipeline Insight
https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight

Stereotactic Surgery Devices Market
https://www.delveinsight.com/report-store/stereotactic-surgery-devices-market

Acute lymphocytic leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphocytic-leukemia-all-market

Eczema Market
https://www.delveinsight.com/report-store/eczema-market

Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market

Hemostats Market
https://www.delveinsight.com/report-store/hemostats-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Peripheral Vascular Devices Market
https://www.delveinsight.com/report-store/peripheral-vascular-devices-market

Obesity Market
https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market

Urinary Incontinence Market
https://www.delveinsight.com/report-store/urinary-incontinence-market

Hemostasis Market
https://www.delveinsight.com/report-store/hemostasis-market

Intracardiac Echocardiography Devices Market
https://www.delveinsight.com/report-store/intracardiac-echocardiography-devices-market

Emphysema Market
https://www.delveinsight.com/report-store/emphysema-market

Hairy Cell Leukemia (HCL) Market
https://www.delveinsight.com/report-store/hairy-cell-leukemia-hcl-market

Cancer Cachexia (CC) Market
https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights

Diabetes Market
https://www.delveinsight.com/report-store/diabetes-market

Panuveitis Market
https://www.delveinsight.com/report-store/panuveitis-market

Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market

mRNA Vaccine and Therapeutics Market
https://www.delveinsight.com/report-store/mrna-vaccine-and-therapeutics-market

Negative Pressure Wound Therapy Systems Market
https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market

Hematuria Market
https://www.delveinsight.com/report-store/hematuria-market

Smart Inhalers Market
https://www.delveinsight.com/report-store/smart-inhalers-market

Audiology Devices Market
https://www.delveinsight.com/report-store/audiology-devices-market

Deep Brain Stimulation Devices Market
https://www.delveinsight.com/report-store/deep-brain-stimulation-devices-market

Prosthetic Heart Valve Market
https://www.delveinsight.com/report-store/prosthetic-heart-valve-market

Tongue Cancer Market
https://www.delveinsight.com/report-store/tongue-cancer-market

Cancer Vaccines Market
https://www.delveinsight.com/report-store/cancer-vaccines-market

CAR-T Pipeline Insight
https://www.delveinsight.com/report-store/car-t-pipeline-insight

Concussions Market
https://www.delveinsight.com/report-store/concussions-market

Total Knee Arthroplasty Market
https://www.delveinsight.com/report-store/total-knee-arthroplasty-market

Physiotherapy Equipment Market
https://www.delveinsight.com/report-store/physiotherapy-equipment-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

Persistent Depressive Disorder Market
https://www.delveinsight.com/report-store/persistent-depressive-disorder-market

Anti-hypertension Market
https://www.delveinsight.com/report-store/anti-hypertension-market

Seborrhoeic Dermatitis Market
https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market

Spirometers Market
https://www.delveinsight.com/report-store/spirometers-market

Tumor Ablation Market
https://www.delveinsight.com/report-store/tumor-ablation-market

Migraine Market
https://www.delveinsight.com/report-store/migraine-market

Pegfilgrastim Biosimilar
https://www.delveinsight.com/report-store/pegfilgrastim-biosimilar-insight

Renal Vasculitis Market
https://www.delveinsight.com/report-store/renal-vasculitis-market

Dense Deposit Disease Market
https://www.delveinsight.com/report-store/dense-deposit-disease-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atopic Keratoconjuctivitis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Akari Therapeutics, Allakos here

News-ID: 3279566 • Views:

More Releases from DelveInsight Business Research LLP

Pharmaceutical Contract Manufacturing Market Forecast Report 2032: Size, Share, and Strategic Insights by DelveInsight
Pharmaceutical Contract Manufacturing Market Forecast Report 2032: Size, Share, …
DelveInsight's Pharmaceutical Contract Manufacturing Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceutical Contract Manufacturing Companies market shares, challenges, Pharmaceutical Contract Manufacturing Market Drivers, barriers, trends, and key market Pharmaceutical Contract Manufacturing companies in the market. To read more about the latest highlights related to the Pharmaceutical Contract Manufacturing Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/pharmaceutical-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key
Pharmaceuticals Market Forecast Report 2032: Size, Share, and Strategic Insights by DelveInsight
Pharmaceuticals Market Forecast Report 2032: Size, Share, and Strategic Insights …
DelveInsight's Pharmaceuticals Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceuticals Companies market shares, challenges, Pharmaceuticals Market Drivers, barriers, trends, and key market Pharmaceuticals companies in the market. To read more about the latest highlights related to the Pharmaceuticals Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/pharmaceutical-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Pharmaceuticals Market Report • In July 2025, Sanofi announced the
Checkpoint Inhibitors Competitive Landscape Report 2025: Emerging Therapies, Leading Companies, and Future Outlook
Checkpoint Inhibitors Competitive Landscape Report 2025: Emerging Therapies, Lea …
DelveInsight's, "Checkpoint Inhibitors Competitive landscape 2025" report provides comprehensive insights about 50+ companies and 60+ drugs in Checkpoint Inhibitors Competitive landscape. It covers the Checkpoint Inhibitors Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the full insights into the evolving Checkpoint Inhibitors Pipeline and discover which companies are leading the innovation race @ Checkpoint Inhibitors Competitive
Surgical Simulation Market Forecast Report 2032: Size, Share, and Strategic Insights by DelveInsight
Surgical Simulation Market Forecast Report 2032: Size, Share, and Strategic Insi …
DelveInsight's Surgical Simulation Market Insights Report 2032 provides the current and forecast market analysis, individual leading Surgical Simulation Companies market shares, challenges, Surgical Simulation Market Drivers, barriers, trends, and key market Surgical Simulation companies in the market. To read more about the latest highlights related to the Surgical Simulation Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/surgical-simulation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Surgical Simulation Market

All 5 Releases


More Releases for Atopic

Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Atopic Dermatitis Market Size By 2025? The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Atopic Dermatitis Pipeline
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029. Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”. In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to